ADVANCED MATERIALS & DEVICES — Department of Defense STTR Phase I: DHA22B-001
ADVANCED MATERIALS & DEVICES — STTR Phase I award from Department of Defense.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $250,000. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code DHA22B-001 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $250,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- STTR · Phase I
- Topic
- DHA22B-001
- Solicitation
- 22.B
- NAICS
- —
- Place of performance
- NV
- Period
- 2022-09-20 → 2023-04-22
Description
This Small Business Technology Transfer Phase I effort aims at the feasibility of developing a low-cost, modular human surrogate including a sensory system and organ models with integrated pressure sensors. The proposed system will be utilized for evaluating personal protective equipment (PPE). Current human surrogates are either costly or do not provide adequate pressure measurements. The proposed blast acquisition test system will include Advanced Materials and Devices’ (AMAD) OmniBlast sensors modified for integration into an anatomically correct surrogate. The torso with head, brain, neck, lungs, and neurosensory organs will be 3D printed or molded. Trade studies will be performed on materials selection, number of sensors, and sensor placement. In the Phase I effort, feasibility will be demonstrated by testing and evaluating the proposed surrogate under blast loading conditions from 5 to 25 psi, using AMAD’s blast chamber. The low-fidelity anatomically correct prototype of a sensor-integrated surrogate along with the blast test data will be delivered. In the Phase II effort, the prototypes will be improved for modularity and will be fabricated with biofidelic materials against biological biomechanical models. In addition, software will be released for data analysis, and a roadmap for the Phase III effort will be developed.